NCT02955862

Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report

Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report From June 2015 to June 2016

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 1,177 (actual)
• Sponsor: National Hospital for Tropical Diseases, Hanoi, Vietnam · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

CRICS financial report for the first budget year of the study

Detailed description

Vietnam Cryptococcal Retention in Care Study (CRICS) federal financial report for the first budget year of the study

Conditions

• Cryptococcal Meningitis

Interventions

Type	Name	Description
OTHER	Vietnam Cryptococcal Retention in Care Study (CRICS)	Drug: Fluconazole HIV-infected patients with CD4 ≤100 cells/μL who present for HIV care at outpatient clinics (OPCs) in Vietnam where CrAg screening is offered will be recruited into the study. Study participants will be screened for cryptococcal antigen using the Lateral Flow Assay (LFA). Those who are CrAg-positive, but have no features of central nervous system (CNS) disease, will be treated with high-dose fluconazole. Other Names: • Fluconazole

Timeline

• Start date: 2015-06-01
• Primary completion: 2017-09-01
• Completion: 2017-09-01
• First posted: 2016-11-04
• Last updated: 2018-03-29

Locations

1 site across 1 country: Vietnam